Fulgent Historical Cash Flow
| FLGT Stock | USD 20.24 0.11 0.55% |
Analysis of Fulgent Genetics cash flow over time is an excellent tool to project Fulgent Genetics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 4.6 M or Change In Working Capital of 3 M as it is a great indicator of Fulgent Genetics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Fulgent Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fulgent Genetics is a good buy for the upcoming year.
Fulgent |
About Fulgent Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Fulgent balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Fulgent's non-liquid assets can be easily converted into cash.
Fulgent Genetics Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Fulgent Genetics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Change Receivables is comparatively stable compared to the past year. Cash And Cash Equivalents Changes is likely to gain to about 93.5 M in 2024, whereas Change In Cash is likely to drop slightly above 10.6 M in 2024.
Fulgent Genetics cash flow statement Correlations
Click cells to compare fundamentals
Fulgent Genetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fulgent Genetics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (21K) | (62K) | (4.2M) | (76.1M) | (27.8M) | (26.4M) | |
| Investments | (27.9M) | (289.9M) | (460.9M) | (261.3M) | 38.9M | 40.8M | |
| Change In Cash | 5.2M | 75.5M | 77.5M | (85.4M) | 18.0M | 10.6M | |
| Free Cash Flow | 4.2M | 104.1M | 514.7M | 234.7M | 4.8M | 4.6M | |
| Change In Working Capital | (915K) | (91.5M) | (2.7M) | 2.0M | 2.8M | 3.0M | |
| Begin Period Cash Flow | 6.7M | 12.0M | 87.4M | 164.9M | 79.5M | 40.4M | |
| Total Cashflows From Investing Activities | (29.0M) | (326.4M) | (546.5M) | (261.3M) | (235.2M) | (223.4M) | |
| Other Cashflows From Financing Activities | 38K | 104K | 96K | 31K | (15.0M) | (14.2M) | |
| Depreciation | 2.1M | 3.0M | 11.0M | 32.7M | 31.8M | 33.3M | |
| Other Non Cash Items | 1.5M | 8.0M | 16.0M | 43.5M | 109.7M | 115.2M | |
| Capital Expenditures | 1.3M | 36.5M | 23.8M | 18.8M | 22.2M | 12.9M | |
| Total Cash From Operating Activities | 5.5M | 140.6M | 538.6M | 253.5M | 27.0M | 25.7M | |
| Change To Account Receivables | (839K) | (178.5M) | 42.3M | 68.6M | 2.4M | 2.5M | |
| Change To Operating Activities | 229K | 11.1M | 19.8M | (40.5M) | (36.4M) | (34.6M) | |
| Net Income | (411K) | 214.3M | 506.2M | 141.9M | (167.8M) | (159.4M) | |
| Total Cash From Financing Activities | 28.8M | 261.3M | 85.4M | (77.1M) | (47.8M) | (45.4M) | |
| End Period Cash Flow | 12.0M | 87.4M | 164.9M | 79.5M | 97.5M | 50.9M | |
| Other Cashflows From Investing Activities | 3.3M | (27.9M) | (1.4M) | (81.8M) | (73.7M) | (70.0M) | |
| Change To Netincome | 4.2M | 8.7M | 22.9M | 75.5M | 86.8M | 91.1M | |
| Change To Liabilities | (41K) | 108.6M | (12.2M) | (25.3M) | (29.1M) | (27.7M) | |
| Stock Based Compensation | 3.2M | 8.2M | 15.9M | 32.6M | 42.9M | 45.1M | |
| Change Receivables | (2.0M) | (839K) | (178.5M) | 42.3M | 38.1M | 40.0M | |
| Cash And Cash Equivalents Changes | 246K | 5.2M | 75.4M | 77.4M | 89.0M | 93.5M | |
| Cash Flows Other Operating | 91K | 378K | (16.3M) | 4.4M | 4.0M | 4.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.